Citigroup Initiates Coverage On 2seventy bio with Buy Rating, Announces Price Target of $13
Portfolio Pulse from Benzinga Newsdesk
Citigroup analyst Samantha Semenkow has initiated coverage on 2seventy bio (NASDAQ:TSVT) with a Buy rating and a price target of $13.
October 12, 2023 | 12:26 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Citigroup has initiated coverage on 2seventy bio with a Buy rating and a price target of $13, which could positively impact the stock's performance.
The initiation of coverage by Citigroup, a major financial institution, with a Buy rating indicates a positive outlook for 2seventy bio. The price target of $13 suggests potential upside, which could attract investors and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100